Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice daily1

AIMS: To assess treatment satisfaction and weight-related quality of life (QOL) in subjects with Type 2 diabetes treated with exenatide once weekly (QW) or twice daily (BID). METHODS: In this 52-week randomized, multi-centre, open-label study, 295 subjects managed with diet and exercise and/or oral...

Descripción completa

Detalles Bibliográficos
Autores principales: Best, J H, Boye, K S, Rubin, R R, Cao, D, Kim, T H, Peyrot, M
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2009
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776933/
https://www.ncbi.nlm.nih.gov/pubmed/19573122
http://dx.doi.org/10.1111/j.1464-5491.2009.02752.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776933/
https://www.ncbi.nlm.nih.gov/pubmed/19573122
http://dx.doi.org/10.1111/j.1464-5491.2009.02752.x

Ejemplares similares